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ABSTRACT
In vitro selection and directed evolution of peptides
from mRNA display are powerful strategies to find
novel peptide ligands that bind to target bio-
molecules. In this study, we expanded the mRNA
display method to include multiple nonnatural
amino acids by introducing three different four-
base codons at a randomly selected single position
on the mRNA. Another nonnatural amino acid may
be introduced by suppressing an amber codon that
may appear from a (NNK)n nucleotide sequence on
the mRNA. The mRNA display was expressed in an
Escherichia coli in vitro translation system in the
presence of three types of tRNAs carrying different
four-base anticodons and a tRNA carrying an amber
anticodon, the tRNAs being chemically amino-
acylated with different nonnatural amino acids. The
complexity of the starting mRNA-displayed peptide
library was estimated to be 1.1 3 10
12 molecules.
The effectiveness of the four-base codon media-
ted mRNA display method was demonstrated in
the selection of biocytin-containing peptides on
streptavidin-coated beads. Moreover, a novel
streptavidin-binding nonnatural peptide containing
benzoylphenylalanine was obtained from the non-
natural peptide library. The nonnatural peptide
libraryfromthefour-basecodonmediatedmRNAdis-
play provides much wider functional and structural
diversity than conventional peptide libraries that
are constituted from 20 naturally occurring amino
acids.
INTRODUCTION
In vitro selection and directed evolution of peptide library
are useful techniques for ﬁnding novel ligands that bind to
target biomolecules. Several strategies for linking genotypes
(genes) and phenotypes (peptides) have been developed,
including phage display (1,2), ribosome display (3–5) and
mRNA display (6–9). In particular, mRNA display strategy,
in which covalently linked conjugates of an mRNA and its
peptide product are synthesized in an in vitro translation sys-
tem, is advantageous for its large library size and the stable
mRNA–peptide linkage. Peptide ligands that bind to target
molecules, such as ATP (10), streptavidin (11) and human
a-thrombin (12) have been successfully obtained by using
the mRNA display.
Because these directed evolution processes are essentially
based on the biochemical translation of mRNA library, the
diversity of the amino acids is limited within the 20 naturally
occurring amino acids. Recent ﬁndings on peptide drugs, how-
ever, revealed that introduction of nonnatural amino acids is
one of essential points for successful drug discovery (13,14).
Since the mRNA display strategy is more advantageous than
the synthetic peptide library in its large library size and its
potentiality for directed evolution, introduction of nonnatural
amino acids into the mRNA display strategy is a promising
approach towards a widely applicable and highly ﬂexible
technique for ﬁnding useful peptide ligands and drugs.
Incorporation of nonnatural amino acids into biochemic-
ally expressed proteins has been ﬁrst carried out on the basis
of the stop-codon suppression in the presence of a chemically
aminoacylated suppressor tRNA (15,16). Recently, the stop-
codon suppression strategy has been introduced to an mRNA
display to construct a peptide library containing a single non-
natural amino acid (17). The stop-codon suppression method,
however, is limited to incorporate only a single nonnatural
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doi:10.1093/nar/gnj003amino acid along a peptide, since the types of the stop
codons that can be assigned to nonnatural amino acids are
practically limited only to an amber (UAG) codon or, in
limited cases, to other stop codons.
We have been developing a four-base codon strategy for
incorporating multiple nonnatural amino acids into speciﬁc
positions of proteins (18–20). Actually, two different non-
natural amino acids have been incorporated independently
into single proteins (20). Introduction of the four-base codon
strategy into the mRNA display method will, therefore, be a
promising approach to construct a peptide library that contains
multiple nonnatural amino acids.
In this study, we constructed a peptide library containing
multiple nonnatural amino acids from an mRNA that con-
tained three four-base codons AGGU, CGGU and GGGU,
at a randomly selected single position. The mRNA may
also contain an amber codon in the (NNK)n sequence at
random positions. The effectiveness of the expanded peptide
library was demonstrated by the recovery of biocytin-
containing peptides from the peptide library by selection
with streptavidin-coated beads. Moreover, we have iso-
lated a novel streptavidin-binding peptide that contains a
nonnatural amino acid. These results indicate that the four-
base codon mediated mRNA display to construct a library
of nonnatural peptides provides a widely applicable and
highly ﬂexible method for ﬁnding effective peptide ligands
and drugs.
MATERIALS AND METHODS
Library construction
A DNA library (167mer) encoding H2N-MASMTGGQQ-
MGZX9-MGMSGS-COOH (Z indicates one of three types
of nonnatural amino acids encoded by three four-base codons,
and X indicates 1 of 20 naturally occurring amino acids plus
a nonnatural amino acid encoded by UAG codon) was con-
structed by PCR using two primers. A 50 primer T7proSD
(50-GAAATTAATACGACTCACTAT-AGGGAGACCAC-
AACGGTTTCCCTCTAGAAATAATTTTGTT-TAACTT-
TAAGAAGGAGATATACATATGGCTAGCATGAC-30)
contained a T7 promoter, a 50 stem–loop and a Shine–
Dalgarno ribosome binding site. A 30 primer T7tagZX9CR
(50-AGATCCAGA-CATTCCCAT(MNN)9ACCBACCCAT-
TTGCTGTCCACCAGTCA-TGCTAGCCATATGTATAT-
CTCCTTCTT-30, where M indicates A or C, N indicates A, C,
GorT,andBindicates C,GorT)containedaT7tag sequence,
a random sequence VGGT(NNK)9, and a 30 constant region.
The PCR product was puriﬁed by using QIAquick PCR puri-
ﬁcation kit (Qiagen), and ampliﬁed by PCR using a 50 primer
T7pro (50-GAAATTAATACGACTCACTA-30) and a 30
primer CR (50-AGATCCAGACATTCCCAT-30). The PCR
product was puriﬁed by using the PCR puriﬁcation kit, and
transcribed to mRNA by using T7 RNA polymerase. The
mRNA was then ligated with a 30-puromycin-oligonucleotide
50-AAAAAAAAAAAAAAAAAAAAAAAAAAACCP-30
(prepared by Japan Bio Service, P indicates 30-puromycin)
by using a DNA splint oligonucleotide and T4 DNA ligase
(New England Biolabs). The resulting product was puriﬁed
by 4% PAGE with 7 M urea.
Formation of mRNA-displayed peptide library
The puromycin-linked mRNA was translated in an Escheri-
chia coli in vitro translation system in the presence of
tRNAs chemically aminoacylated with nonnatural amino
acids. Aminoacyl-tRNAs were prepared by a chemically
aminoacylation technique as reported previously (18,19). In
the case of biocytin-containing peptide library, one of tRNAs
with ACCC, ACCG, ACCU and CUA anticodons was
aminoacylated with biocytin, and the others were aminoacyl-
ated with nonnatural amino acids listed in Table 1 (Run A–D).
Translation was carried out in 30 ml of a reaction mixture
containing 55 mM HEPES–KOH, pH 7.5, 210 mM potassium
glutamate, 6.9 mM ammonium acetate, 12 mM magn-
esium acetate, 1.7 mM DTT, 1.2 mM ATP, 0.28 mM GTP,
26 mM phosphoenolpytuvate, 1 mM spermidine, 1.9%
polyethyleneglycol-8000, 35 mg/ml folinic acid, 0.1 mM of
each amino acid, 10 mM anti-tmRNA oligonucleotide (5),
30 U of ribonuclease inhibitor (Takara Bio), 4.8 mgo f
mRNA-dA27dCdCP, 3.3 mM of each nonnatural aminoacyl-
tRNA and 6 mlo fE.coli S-30 extract (Promega). The reaction
mixture was incubated at 25 C for 10 min, then cooled on ice
for 40 min. Peptide transfer to puromycin moiety of the
mRNA-dA27dCdCP was facilitated by additional incubation
at 10 C for 1 h in the presence of 500 mM KCl. After incuba-
tion, EDTA (ﬁnal concentration 20 mM) was added to disso-
ciate the ribosome complex. Then the mixture was incubated
at 37 C for 20 min after addition of 1 vol of saturated
NaHCO3. This treatment hydrolyzed an ester bond of the
remaining aminoacyl-tRNAs without degradation of mRNA
portion of the mRNA-displayed peptide. The resulting solu-
tion was neutralized with 2 ml of acetic acid, and gel-ﬁlterated
with MicroSpin G-25 column (Amersham Bioscience) to
remove free nonnatural amino acids and to exchange to
TBK buffer (50 mM Tris–HCl, pH 7.4, 500 mM KCl, 5 mM
EDTA, 0.5 mg/ml BSA and 0.05% Tween 20). Formation of
the mRNA-displayed peptide was conﬁrmed on 15% SDS–
PAGE followed by western blotting using an anti-T7 tag
antibody (Novagen) and an alkaline phosphatase-labeled
anti-mouse IgG (Promega).
MS measurement of peptide containing
nonnatural amino acids
The nonnatural amino acids were incorporated into T7tag-
XSNHHHHHHK-FABP (FABP; fatty acid binding protein)
by using CGGU codon, in which X indicates nonnatural
amino acid. Cell-free translation mixture (50 ml) was loaded
Table 1. The amount of collected mRNA-displayed nonnatural peptide
Run Nonnatural
aminoacyl-tRNA
Collected
mRNA-displayed peptide
(molecules/30 mlo f
in vitro translation)
A biotytin-tRNAACCU bzoPhe-tRNAACCG
azoAla-tRNAACCC napAla-tRNACUA 3.9 · 10
7
B bphAla-tRNAACCU biocytin-tRNAACCG
azoAla-tRNAACCC napAla-tRNACUA 8.5 · 10
8
C bphAla-tRNAACCU bzoPhe-tRNAACCG
biocytin-tRNAACCC napAla-tRNACUA 4.1 · 10
8
D bphAla-tRNAACCU bzoPhe-tRNAACCG
azoAla-tRNAACCC biocytin-tRNACUA 1.2 · 10
8
E bphAla-tRNAACCU bzoPhe-tRNAACCG
azoAla-tRNAACCC napAla-tRNACUA 5.1 · 10
6
e4 Nucleic Acids Research, 2006, Vol. 34, No. 1 PAGE 2 OF 9onto 20 ml of MagneHis Ni-Particles (Promega). The beads
were washed ﬁve times with 200 ml wash buffer that contained
10 mM Tris–HCl, pH 7.5 and 100 mM NaCl, and then
eluted with 25 ml elution buffer that contained 10 mM
Tris–HCl, pH 7.5 and 500 mM imidazole. The eluate was
mixed 0.1 AU of lysylendopeptidase (Wako Chemicals),
then incubated at 37 C for 6 h. The resulting peptide frag-
ments were desalted and concentrated by using ZipTipC18
(Millipore) and eluted with a matrix solution that contained
saturated a-cyano-4-hydroxycinnamic acid in 50% acetoni-
trile and 0.1% TFA. The mass measurement was performed
by MALDI-TOF MS (Voyager, Applied Biosystems) in the
positive mode using angiotensin II as an external calibrant.
In vitro selection
Dynabeads M-280 Streptavidin (Dynal) (20 ml) were washed
ﬁve times with 100 ml TBS buffer (50 mM Tris–HCl, pH 7.5
and 150 mM NaCl). The beads were gently agitated in 50 ml
of 50 mg/ml biotin-BSA (Sigma) in TBS at room tempera-
ture for 30 min. The beads were washed ﬁve times with 100 ml
TBS buffer, and gently agitated in 50 ml of 0.4 mg/ml strep-
tavidin (Vector) in TBS at room temperature for 30 min. After
washing ﬁve times with 100 ml TBS buffer, the beads
were gently agitated in the mRNA-displayed peptide solution
at 4 C for 1 h. The resulting beads were washed four times
with 100 ml TBK at 4 C for 10 min, four times with 100 mlo f
4 M urea, and twice with 100 ml water (21). Then, mRNA-
displayed peptides bound to the beads were eluted with elution
buffer (10 mM EDTA and 95% formamide) by heating at
65 C for 5 min. The eluate was ethanol-precipitated, and
the pellet was dissolved in 2 ml water.
RT–PCR and quantification of mRNA
Collected mRNA-displayed peptides were reverse-transcribed
by using ReverTra Ace (TOYOBO). A reaction mixture
(10 ml), which contained 50 mM Tris–HCl, pH 7.5, 75 mM
KCl, 3 mM MgCl2, 10 mM DTT, 1 mM each dNTP, 0.5 mM
30 primer CR and 1 ml of collected mRNA-displayed peptide
solution, were heated at 70 C for 5 min. After cooling to 55 C,
50 U of ReverTra Ace was added, then the resulting mixture
was incubated at 55 C for 5 min, and heated at 99 C for 5 min.
Real-time quantitative PCR using a 50-BODIPY FL-labeled
primer (22) was carried out on Smart Cycler (Cephied) with an
initial denaturation at 98 C for 10 s, primer annealing at 55 C
for 2 s, and extension at 74 C for 20 s. The reaction mixture
(25 ml) contained 20 mM Tris–HCl, pH 8.2, 2 mM MgSO4,
10 mM (NH4)2SO4, 10 mM KCl, 0.1% Triton X-100,
0.1 mg/ml BSA, 0.1 mM BODIPY FL-labeled primer
50loop-7 (50-BODIPY FL-CACAACGGTTTCCCTCTA-
GAAAT-30), 0.25 U of KOD Dash (TOYOBO) and 5 mlo f
the reverse-transcribed products. Fluorescence was measured
afterextensionineach cycle,andthePCRwasstoppedafter60
cycles. The amount of collected mRNA-displayed peptides
was determined from a standard curve for serial dilutions
(10
6–10
11 molecules/ml) of the mRNA. The real-time PCR
product (138 bp) was puriﬁed by 8% PAGE, and ampliﬁed
by PCR using a 50 primer 50loop (50-GGGAGACCACAA-
CGGTTTCCCTCT-30) and 30 primer CR.
For sequencing, the PCR product was cloned into pGEM-T
Vector (Promega), and individual colonies were picked for
direct PCR ampliﬁcation and sequencing.
In vitro selection of streptavidin-binding
nonnatural peptides
In order to prepare DNA library encoding H2N-
MASMTGGQQMGXnZX(9–n)MGMSGS-COOH (n ¼ 0–9),
10 PCR processes were carried out by using a 50 primer
T7proSD and 30 primer T7tagXnZX(9–n)CR (50-AGATCCAG-
ACATTCCCAT-(MNN)(9–n)ACCB(MNN)nACCCATTTGC-
TGTCCACCAGTCATG-CTAGCCATATGTATATCTCCT-
TCTT-30), respectively. The PCR products were combined,
Figure 1. (A) Nucleotide and amino acid sequence of a nonnatural peptide library. Z indicates one of three types of nonnatural amino acids encoded by four-base
codons VGGT, and X indicates 1 of 20 naturally occurring amino acids and TAG-encoded nonnatural amino acid. (B) Structures of nonnatural amino acids used
in this study.
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described above. In vitro translation was done in the presence
of tRNAs aminoacylated with nonnatural amino acids as
shown in Table 1 (Run E). Collection of mRNA-displayed
peptides that bind to streptavidin was performed as described
above, and the resulting RT–PCR products were ampliﬁed by
PCR using a 50 primer +T7pro (50-GAAATTAATACGACT-
CACTATAGGGAGACCACAACGGTT-30) and a 30 primer
CR, followed by transcription to mRNA. After eight rounds
of selection, PCR products were cloned and sequenced.
Figure 2. MALDI-TOF MS measurements of digested peptide ASMTGGQQMGXSNHHHHHHK obtained from T7tag-XSNHHHHHHK-FABP containing
biocytin (A), bphAla (B), bzoPhe (C), azoAla (D) and napAla (E) at X position. The MS spectra were externally calibrated with angiotensin II (1046.5).
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Library design
A DNA library encoding 27mer polypeptides containing
10 randomized natural and nonnatural amino acids,
(NNK)nVGGT(NNK)(9–n), was designed as shown in
Figure 1A. The randomized region consists of a single four-
base codon VGGT (V indicates A, C or G), and nine NNK
codons (K indicates G or T). Four-base codons AGGT, CGGT
and GGGT were chosen to encode nonnatural amino acids,
because these four-base codons were found to be successfully
decoded by the tRNAs containing the complementary four-
base anticodons in an E.coli in vitro translation system (20).
Amber codon TAG that may appear in the randomized
(NNK)n region was also utilized to encode a nonnatural
amino acid by using an amber suppressor tRNA. The use of
amber suppressor tRNA was also effective to decrease the
possibility of terminating of peptide elongation. The theoret-
ical diversity of the library amounts 21
9 (nonapeptide of
20 natural amino acids plus 1 TAG-encoded nonnatural
amino acid) times 30 (10 positions of 3 nonnatural amino
acids decoded by four-base codons) ¼ 2.4 · 10
13 different
peptide sequences. Moreover, the nonnatural peptide library
adds high degree of functional and structural diversity to the
peptide sequences.
The randomized region was linked with a T7 tag at the
N-terminal for efﬁcient translation in the E.coli in vitro trans-
lation system and for easy detection by an anti-T7 tag anti-
body, and with a 30 constant region at the C-terminal to ligate
a DNA linker containing puromycin at the 30 end.
Selective enrichment of mRNA-displayed
peptides containing biocytin
To demonstrate the feasibility of the four-base codon mediated
mRNA display method to construct a nonnatural peptide lib-
rary, selective enrichment of peptides containing a particular
nonnatural amino acid from a DNA library VGGT(NNK)9
(n ¼ 0 in Figure 1A) was investigated. We have chosen
biocytin (Figure 1B), a strong binder to streptavidin, as the
nonnatural component and examined if the biocytin-
containing peptides are enriched in the selection processes
on streptavidin-coated beads. Biocytin was incorporated
into peptides by one of three four-base codons AGGU,
CGGU and GGGU, or by an amber codon UAG. A tRNA
that carries one of the three complementary four-base anti-
codons or a CUA anticodon was aminoacylated with bio-
cytin by chemical aminoacylation method. Codons other
than biocytin-encoding one were used to introduce three of
the four nonnatural amino acids, p-biphenylalanine (bphAla),
p-benzoylphenylalanine (bzoPhe), p-phenylazophenylalanine
(azoAla) and 2-naphthylalanine (napAla) (Figure 1B).
Incorporation of the nonnatural amino acids was conﬁrmed
by mass spectrometry as shown in Figure 2. The nonnatural
amino acids were incorporated into T7tag-XSNHHHHHHK-
FABP (X indicates nonnatural amino acid). The cell-free
translation product was puriﬁed by Ni-afﬁnity beads and
digested by lysylendopeptidase, then the resulting peptide
fragments were analyzed by MALDI-TOF MS. The mass
peaks corresponding to the Met-processed peptide ASMT-
GGQQMGXSNHHHHHHK were observed for biocytin
(calcd, 2473.1; found, 2472.9), bphAla (calcd, 2342.0;
found, 2341.8), bzoPhe (calcd, 2370.0; found, 2369.4), azoAla
(calcd, 2370.0; found, 2370.0) and napAla (calcd, 2316.0;
found, 2315.9). These results support the incorporation of
the nonnatural amino acids into the mRNA-displayed peptide
library.
A DNA library VGGT(NNK)9 was transcribed using T7
RNA polymerase, and the resulting mRNA was ligated to a
DNA linker containing 30 puromycin (8). Then, 3.6 · 10
13
molecules of puromycin-ligated mRNA were added to an
E.coli in vitro translation system with four nonnatural
aminoacyl-tRNAs to generate mRNA-displayed nonnatural
peptide library (5,8,18).
The formation of mRNA-displayed peptide was conﬁrmed
by western blotting using an anti-T7 tag antibody (Figure 3).
When puromycin was linked to the 30 end of mRNA, mRNA-
displayed peptide was observed at around 60 kDa, which
disappeared after treatment with either RNase A or Proteinase
K. On the other hand, no product was detected in the absence
of the 30 puromycin. This result indicates that the mRNA and
translated peptide were successfully linked together through
the 30 puromycin.
When an mRNA-displayed peptide was synthesized using
a streptavidin mRNA containing A12dU(FITC)A14CCP at the
30-terminal, the yield of the mRNA-displayed peptide was
estimated to be 6% of the input mRNA by ﬂuorescence
image of PAGE (data not shown). The same experiment
was carried out using a mRNA-A12dU(FITC)A14CCP encod-
ing VGGT(NNK)9 peptide, but the yield could not be deter-
mined because of a broad smearing band of the mRNA with
the random VGGT(NNK)9 sequence. When the yield of
the mRNA-displayed peptide for the nonnatural peptide lib-
rary was assumed to be similar to that for the streptavidin
mRNA and the average decoding efﬁciency of the four-
base and amber codons was assumed to be 50% (20), the
number of the mRNA-displayed peptide was expected to
be 1.1 · 10
12 (3% of 3.6 · 10
13)i n3 0ml of cell-free trans-
lation. Although this value was lower than that for rabbit
reticulocyte (9 · 10
13/ml) and wheat germ (1 · 10
14/ml)
cell-free systems, it was much higher than that for phage
display (1 · 10
9) (2,8,9).
Then, the mRNA-displayed peptide library containing bio-
cytin was collected by using streptavidin-coated magnetic
Figure 3. WesternblotanalysisofmRNA-displayednonnaturalpeptidelibrary
generated in an E.coli in vitro translation system in the presence of bphAla-
tRNAACCU, biocytin-tRNAACCG, azoAla-tRNAACCC, napAla-tRNACUA.
Lane 1 containedan mRNA-dA27 without puromycin,and lanes 2–4 contained
a mRNA-dA27dCdC-puromycin. The mRNA-displayed nonnatural peptide
library was treated with RNase A (lane 3) and Proteinase K (lane 4).
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formamide, and reverse-transcribed to cDNA. The resulting
cDNA was ampliﬁed by a real-time quantitative PCR using a
50-BODIPY FL-labeled primer (22). The ﬂuorescence intens-
ity of BODIPY FL decreased with the increase of the amount
of PCR product, and the amount of the collected mRNA-
displayed peptide was estimated by using a standard curve.
As shown in Table 1, 3.9 · 10
7 to 8.5 · 10
8 molecules of
mRNA-displayed peptide were collected when one of the
tRNAs aminoacylated with biocytin was added to the
in vitro translation system. On the contrary, 5.1 · 10
6
molecules of mRNA-displayed peptide were recovered
when no biocytin-tRNA was added. These results indicate
that the mRNA-displayed peptides containing biocytin were
collected in a highly speciﬁc manner.
The real-time PCR product was ampliﬁed, cloned and
sequenced (Figure 4). When the peptide library was construc-
ted in the presence of biocytin-tRNAACCU, 8 out of 10 clones
(80%) contained AGGT four-base codon. The lacks of base in
some DNA sequences may be generated during PCR. In these
DNA sequences, the peptide synthesis may be continued with
frameshifting at any positions. Ten out of ten clones (100%)
contained CGGT in the case of biocytin-tRNAACCG, and ten
out of eleven clones (91%) contained GGGT in the case of
Figure4.SequenceanalysesofcollectedmRNA-displayedpeptidesfromaDNAlibraryVGGT(NNK)9withbiocytin-tRNAs.Biocytinwasintroducedintopeptides
by using tRNAACCU (A), tRNAACCG (B), tRNAACCC (C) and tRNACUA (D). BIO, BPH, BZO, AZO and NAP in amino acid sequence indicate biocytin, bphAla,
bzoPhe, azoAla and napAla, respectively. Asterisks indicate that the DNA sequences that contain deletion mutations, which may be suppressed by frameshifting at
any positions.
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case may be accidentally generated during RT–PCR after
in vitro selection. In addition, eight out of eight clones
(100%) contained an amber codon at various positions in
the case of biocytin-tRNACUA. The eight clones also con-
tained unbiased mixture of four-base codons at the ﬁrst posi-
tion. There is no apparent trend and no similarity to other
streptavidin-binding peptides reported previously. These res-
ults clearly demonstrate that the mRNA-displayed peptides
containing biocytin were speciﬁcally recovered from the
mRNA-displayed peptide library containing four nonnatural
amino acids including a single biocytin, and that these non-
natural amino acids were independently incorporated under
the direction of four-base codons and amber codon. In
addition, the results indicate a successful generation of non-
natural peptide library containing two types of nonnatural
amino acids in single peptides by using both the four-base
codon and the amber codon. This suggests the possibility of
an mRNA-displayed peptide library containing more than
two nonnatural amino acids in single peptides by adding
another four-base codons to the genetic code.
Selection of streptavidin-binding nonnatural peptide
As the second demonstration of the effectiveness of the four-
base codon mediated mRNA display, selection of nonnatural
peptides that bind to streptavidin was constructed. DNA
library of (NNK)nVGGT(NNK)(9–n) (n ¼ 0–9) was prepared
by combining products of 10 oligonucleotide-directed PCR
processes. The mRNA library was expressed in an E.coli
in vitro translation system in the presence of tRNAs
aminoacylated with nonnatural amino acids (Run E in
Table 1). The theoretical diversity of the peptide library
was 2.4 · 10
13, and the number of the mRNA-displayed
peptide containing nonnatural amino acid was estimated to
be 1.1 · 10
12. Thus, the coverage of the synthesized library
was estimated to be 5% of the theoretical complexity.
The selection of the peptides was performed as in the
case of biocytin-containing peptides. The amount of mRNA-
displayed peptide eluted from streptavidin-coated magnetic
beads was quantiﬁed at each selection cycle. The cDNA
library obtained after the RT–PCR of the mRNA-displayed
peptides was used as the template for transcription to pre-
pare mRNA library of the next cycle. After six rounds of
selection cycle, the amount of mRNA-displayed peptide
increased signiﬁcantly (Figure 5A). At the eighth round,
the amount of mRNA-displayed peptide was 120-fold relative
to that of the ﬁrst round, indicating that streptavidin-
binding nonnatural peptides were enriched through the
repeated selection cycles. By cloning and sequencing cDNA
after the eighth round, 12 out of 12 clones were found to
contain a single peptide sequence, APCSSA(bzoPhe)DDV.
The incorporation of benzoylphenylalanine is interpreted
neither by high decoding efﬁciency of the nonnatural amino
Figure 5. Selection of streptavidin-binding nonnatural peptides from an mRNA-displayed nonnatural peptide library containing bphAla, bzoPhe, azoAla and
napAla. (A) The amount of collected mRNA-displayed peptides (molecules/30 mlo fin vitro translation) was quantified by real-time PCR at each selection
cycle. (B) The amount of collected mRNA-displayed peptide at the eighth round of selection. As control experiments, four nonnatural aminoacyl-tRNAs were
replaced by Val-tRNAs (+Val-tRNA), and the selection procedure was performed under the presence of 500 mM biotin (+biotin).
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Actually, the decoding efﬁciency of CGGG four-base codon
by benzoylphenylalanine is lower than those by bipheny-
lalanine and 2-naphthylalanine and a little higher than that
of phenylazophenylalanine (19). Similarly the decoding efﬁ-
ciency of CGGU codon by tRNAACCG is lower than that of
GGGU codon by tRNAACCC (20). Therefore, the recovery of
the nonnatural peptide containing benzoylphenylalanine
was not due to biased decoding of the four-base codons,
but a result of selection processes.
Incorporation of valine instead of nonnatural amino acids
into the eighth round clone signiﬁcantly decreased the
amount of mRNA-displayed peptide (Figure 5B). In addition,
when the selection procedure was performed in the presence
of 500 mM biotin, a very low amount of mRNA-displayed
peptide was recovered. These results indicate that the selec-
ted peptide containing a single benzoylphenylalanine specif-
ically binds to streptavidin. Benzoylphenylalanine itself does
not have afﬁnity to streptavidin, but it may interact with a
hydrophobic biotin-binding site of streptavidin in association
with the surrounding amino acids. Any peptide containing
two nonnatural amino acids was not obtained in the present
experiment, possibly because two hydrophobic residues may
not be needed for the binding to streptavidin.
A bzoPhe containing 10mer peptide APCSSA(bzoPhe)-
DDV labeled with FITC at the N-terminal was chemically
synthesized and its binding activity to streptavidin in solution
was evaluated by ﬂuorescence polarization measurement.
The ﬂuorescence polarization of the FITC-labeled peptide
was, however, not changed upon addition of streptavidin.
This result suggests that the 10mer peptide does not have
the binding activity and the adjacent constant region may
be necessary. Taken together with the result that the amount
of the collected mRNA-displayed peptide was decreased
when bzoPhe was substituted by Val (Figure 5B), the bzoPhe
residue binds to streptavidin in association with the surround-
ing amino acids including constant region.
CONCLUSIONS
Four-base codon mediated mRNA display method was
developed to construct a peptide library that contained mul-
tiple nonnatural amino acids at a randomly selected single
position along a peptide chain. Four-base codons AGGU,
CGGU and GGGU were used to assign three different non-
natural amino acids. Another nonnatural amino acid was also
introduced by suppressing UAG amber codon that appeared
in the (NNK)n nucleotide sequence on the mRNA.
The most important advantage of our strategy is that four
different types of nonnatural amino acids are encoded in
peptide library by three four-base codons and one stop
codon. In addition, it may be possible to obtain ligand peptides
containing two types of nonnatural amino acids in the single
peptide chain. A bzoPhe containing peptide was, in fact, selec-
ted from the nonnatural peptide library containing four types
of nonnatural amino acids in Figure 5. Moreover, peptides
containing biocytin and another nonnatural amino acid were
obtained in Figure 4, although the latter one would not con-
tribute to the binding to streptavidin. These results demon-
strate the advantage of our nonnatural peptide library over
previously reported library containing only one nonnatural
amino acid (17). The present nonnatural peptide library has
a wide functional and structural diversity and will make a
powerful tool to discover new artiﬁcial ligands to target
proteins or other biomolecules.
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